Ticker > Company >

Accretion Nutraveda share price

Accretion Nutraveda Ltd.

  2.04 K   0   0 BSE: 544694 SECTOR: Pharmaceuticals & Drugs

299.00
0 0
BSE: Today, 04:00 PM

Price Summary

Today's High

₹ 299

Today's Low

₹ 299

52 Week High

₹ 303.5

52 Week Low

₹ 150.1

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

216.48 Cr.

Enterprise Value

210.96 Cr.

No. of Shares

0.72 Cr.

P/E

42.71

P/B

6.86

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  43.6

CASH

9.74 Cr.

DEBT

4.23 Cr.

Promoter Holding

73.48 %

EPS (TTM)

₹  7

Sales Growth

110%

ROE

27.68 %

ROCE

30.19%

Profit Growth

102.66 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Index Presence

The company is present in 1Indices.

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year110%
3 Year126.21%
5 YearNA

Profit Growth

1 Year102.66%
3 Year162.38%
5 YearNA

ROE%

1 Year27.68%
3 Year77.04%

ROCE %

1 Year30.19%
3 Year43.28%

Debt/Equity

0.1339

Price to Cash Flow

-22.97

Interest Cover Ratio

12.571

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2026 73.48 0.00
Mar 2026 73.48 0.00
Feb 2026 73.48 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good revenue growth of 126.205019552182% for the Past 3 years.
  • Company has been maintaining healthy ROE of 77.0433666666667% over the past 3 years.
  • Company has been maintaining healthy ROCE of 43.2830666666667% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 12.571.
  • Company has a healthy liquidity position with current ratio of 11.9824.
  • The company has a high promoter holding of 73.48%.

 Limitations

  • Company has negative cash flow from operations of -9.4244.
  • The company has a low EBITDA margin of 0% over the past 5 years.
  • The company is trading at a high EV/EBITDA of 30.1009.

Quarterly Result (All Figures in Cr.)

 Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2023 Mar 2024 Mar 2025 Mar 2026
Net Sales 2.9 5.01 16 33.6
Total Expenditure 2.28 3.78 12.28 26.71
Operating Profit 0.62 1.22 3.72 6.9
Other Income 0.17 0.19 0.01 0.11
Interest 0.19 0.24 0.35 0.54
Depreciation 0.31 0.26 0.22 0.26
Exceptional Items 0 0 0 0
Profit Before Tax 0.29 0.91 3.15 6.21
Tax 0.01 0.09 0.65 1.14
Net Profit 0.28 0.82 2.5 5.07
Adjusted EPS (Rs.) 0.78 2.28 5.14 7

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity and Liabilities
Share Capital 0.36 0.36 0.49 7.24
Total Reserves -0.1 0.72 4.56 28.23
Borrowings 1.37 0.51 2.46 3.78
Other N/C liabilities 0.02 0.01 -0.01 0
Current liabilities 2.41 3.03 3.03 2.53
Total Liabilities 4.06 4.64 10.53 41.78
Assets
Net Block 1.49 1.28 1.83 1.66
Capital WIP 0 0.1 0 0
Intangible WIP 0 0 0 0
Investments 0 0 0 0
Loans & Advances 0 0 0 5.95
Other N/C Assets 0 0 0 3.91
Current Assets 2.57 3.25 8.7 30.26
Total Assets 4.06 4.64 10.53 41.78
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2023 Mar 2024 Mar 2025 Mar 2026
Profit from operations 0.29 0.91 3.15 6.21
Adjustment 0.5 0.5 0.57 0.79
Changes in Assets & Liabilities -0.11 -1.08 -5.29 -14.79
Tax Paid 0 -0.1 -0.65 -1.64
Operating Cash Flow 0.68 0.23 -2.22 -9.42
Investing Cash Flow -0.01 -0.16 -0.87 -14.5
Financing Cash Flow -0.63 -0.04 2.98 25.19
Net Cash Flow 0.04 0.03 -0.1 1.26

Corporate Actions

Investors Details

PARTICULARS Feb 2026% Mar 2026% Jun 2026%
promoters 73.48 73.48 73.48
ankita vivek patel 1.38 1.38 1.38
ankurkumar shantilal pate... 14.70 14.70 14.70
hardik mukundbhai prajapa... 9.64 9.64 9.64
harshad nanubhai rathod 9.64 9.64 9.64
mayur popatlal sojitra 9.64 9.64 9.64
paraskumar vinubhai parma... 14.70 14.70 14.70
pooja harshad rathod 1.38 1.38 1.38
shweta mayur sojitra 1.38 1.38 1.38
vaishaki hardik prajapati... 1.38 1.38 1.38
vivek ashokkumar patel 9.64 9.64 9.64
PARTICULARS Feb 2026% Mar 2026% Jun 2026%
investors 26.52 26.52 26.52
dhirajbhai vaghjibhai kor... - 1.30 1.30
radiant global fund-class... 6.04 1.08 1.08
unicorn fund 6.51 6.59 5.69
sunflower broking private... 1.33 - -

Annual Reports

Title Link
Title Link
Annual Report 2026

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Accretion Nutraveda Stock Price Analysis and Quick Research Report. Is Accretion Nutraveda an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Accretion Nutraveda. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Accretion Nutraveda has a PE ratio of 42.7118450374264 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Accretion Nutraveda has ROA of 19.3782% which is a good sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Accretion Nutraveda has a Current ratio of 11.9824.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Accretion Nutraveda has a ROE of 27.6815%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Accretion Nutraveda has a Debt to Equity ratio of 0.1339 which means that the company has low proportion of debt in its capital.

  • Sales growth: Accretion Nutraveda has reported revenue growth of 109.9958% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Accretion Nutraveda for the current financial year is 20.5219161327377%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Accretion Nutraveda is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Accretion Nutraveda is Rs 7.0004. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Accretion Nutraveda in Ticker for free. Also, one can get the intrinsic value of Accretion Nutraveda by using Valuation Calculators, which are available with a Finology ONE subscription. 

Accretion Nutraveda FAQs

Q1. What is Accretion Nutraveda share price today?
Ans: The current share price of Accretion Nutraveda is Rs 299.

Q2. What is the market capitalisation of Accretion Nutraveda?
Ans: Accretion Nutraveda has a market capitalisation of Rs 216.476 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Accretion Nutraveda?
Ans: The PE ratio of Accretion Nutraveda is 42.7118450374264 and the P/B ratio of Accretion Nutraveda is 6.85770379306707, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Accretion Nutraveda share?
Ans: The 52-week high share price of Accretion Nutraveda is Rs 303.5, and the 52-week low share price of Accretion Nutraveda is Rs 150.1.

Q5. Does Accretion Nutraveda pay dividends?
Ans: Currently, Accretion Nutraveda does not pay dividends. Dividend yield of Accretion Nutraveda is around 0%.

Q6. What are the face value and book value of Accretion Nutraveda shares?
Ans: The face value of Accretion Nutraveda shares is Rs 10, while the book value per share of Accretion Nutraveda is around Rs 43.6006. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Accretion Nutraveda?
Ans: Accretion Nutraveda has a total debt of Rs 4.2282 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Accretion Nutraveda?
Ans: The ROE of Accretion Nutraveda is 27.6815% and ROCE of Accretion Nutraveda is 30.1891%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Accretion Nutraveda a good buy for the long term?
Ans: The Accretion Nutraveda long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Accretion Nutraveda undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Accretion Nutraveda appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Accretion Nutraveda’s financials?
Ans: You can review Accretion Nutraveda’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Accretion Nutraveda
X